FDA-CMS collaboration aims to accelerate Medicare coverage determinations of certain medical devices
The recently proposed TCET rule appears to be too stringent to significantly hasten the Medicare coverage process for device makers.
Recently proposed rule seems too stringent to reduce the lag between FDA approval and Medicare coverage.
In terms of Medicare coverage, 2023 is shaping up to be a fruitful year—here are five of the most significant approvals so far.
The bill is designed to provide Medicare patients faster access to innovative technology approved by the FDA.